Clinical trials
Terminated Phase 1 Esophageal Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Atreca, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Eisai Inc. | 1 |
| GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 |
| Incyte Corporation | 1 |
| Molecular Templates, Inc. | 1 |
| Prelude Therapeutics | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 13 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Carcinoma, Renal Cell | 4 |
| Carcinoma, Transitional Cell | 4 |
| Melanoma | 4 |
| Carcinoma, Hepatocellular | 3 |
| Colorectal Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Breast Neoplasms | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.